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Following the identification of medical tourism as a growth sector by the Malaysian government in 1998,
significant government sector and private-sector investments have been channeled into its development over
the past 15 years. This is unfolding within the broader context of social services being devolved to for-profit
enterprises and ‘market-capable’ segments of society becoming sites of intensive entrepreneurial investment by
both the private sector and the state. Yet, the opacity and paucity of available medical tourism statistics severely
limits the extent to which medical tourism’s impacts can be reliably assessed, forcing us to consider the real
effects that the resulting speculation itself has produced and to reevaluate how the real and potential impacts
of medical tourism are  and should be  conceptualized, calculated, distributed, and compensated for.
Contemporary debate over the current and potential benefits and adverse effects of medical tourism for
destination societies is hamstrung by the scant empirical data currently publicly available. Steps are proposed
for overcoming these challenges in order to allow for improved identification, planning, and development of
resources appropriate to the needs, demands, and interests of not only medical tourists and big business but also
local populations.
Keywords: medical tourism industry; statistical data; destination countries; healthcare commodification; publicprivate health
care investment; entrepreneurial state; Southeast Asia
Responsible Editor: Peter Byass, Umea˚ University, Sweden.
*Correspondence to: Meghann Ormond, Cultural Geography Chair Group, Wageningen University, PO Box
47, 6700 AA, Wageningen, The Netherlands, Email: meghann.ormond@wur.nl
Received: 14 June 2014; Revised: 15 August 2014; Accepted: 15 August 2014; Published: 10 September 2014
P
roponents generally envision how medical tourism
 ‘all the activities related to travel and hosting a
tourist who stays at least one night at the destina-
tion region, for the purpose of maintaining, improving
or restoring health through medical intervention’ (1) 
can be used by destinations to attract foreign exchange,
mitigate health worker brain-drain, and improve health
care and tourism infrastructure (2). Correspondingly,
medical tourism has been actively embraced by govern-
ments and private-sector actors in a growing number
of lower- and middle-income countries as a potentially
powerful economic growth engine. Meanwhile, critics
generally warn that medical tourism may harm destina-
tions by stimulating private health care development
unresponsive to locals’ needs and resources (3). Yet,
although more scholars, governments, and medical bodies
in source countries are calling attention to how medical
tourism may adversely impact both source and destination
societies (4), there has been relatively little outspoken
resistance within destination countries to it.
Those engaging in contemporary debate over the
current and potential benefits and adverse effects of
medical tourism for destination societies generally turn to
sorely inadequate government-reported medical tourism
statistics  widely acknowledged to deploy opaque defini-
tions and creative counting practices  to support their
arguments (5). These statistics render medical tourism’s
actual volumes and contributions so difficult to gauge that
the many estimates and claims made by those on either
side of the debate should be treated with caution (6).
In Malaysia, one of Southeast Asia’s most prominent
medical tourism destinations, national medical tourism
statistics derive from the reported numbers of all foreign
patients treated by Malaysian Healthcare Travel Council
endorsed medical facilities and their associated revenue.
These are published only at the national level, do not
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include all medical facilities, and do not recognize or
measure medical tourism’s diverse subnational direct
and indirect economic and social impacts. Furthermore,
available data indiscriminately encompass all registered
patients with a foreign passport, which by default also
encompass expatriates, migrants, business travelers, and
holiday-makers for whom health care may not be the
main motive for their stay (79). The opacity and paucity
of available figures, therefore, severely limits the extent
to which we can reliably quantify medical tourism’s
impacts in Malaysia. This quantitative void forces us
both to consider the real effects that the speculation
this void has itself produced and to reevaluate how the
real and potential impacts of medical tourism are  and
should be  conceptualized, calculated, distributed, and
compensated for.
In this brief debate piece, we use the lenses of our
diverse engagements with the Malaysian government,
medical tourism industry, and health care providers and
users to relate how medical tourism statistics have been
used in Malaysia and reflect on the limitations of these
framings. We then identify steps to more productively
advance the discussion about the challenges and benefits
of medical tourism.
Proponents’ perspective
The Malaysian government identified medical tourism as
a growth sector during the 199798 Asian financial crisis,
when significant numbers of Indonesians began to turn to
Malaysian private hospitals for affordable, quality health
care. In the following decade, private hospitals  concen-
trated mainly in Penang, Melaka, Selangor, Sarawak, and
Johor  worked alongside and through their respective
state governments; private hospital associations; and the
Malaysian Ministries of Health, Tourism, and Trade and
Industry. They sought to attract not only neighboring
Indonesians  characterized by high volumes yet low per
patient expenditure  but also higher-spending medical
tourists from further afield (e.g. Australia, Bangladesh,
China, India, Japan, Nepal, the United Kingdom, the
United States, and the Middle Eastern countries) (7, 10,
11). The Malaysian government’s investment tax allow-
ance further spurred private health care facilities promot-
ing medical tourism to invest in internationally recognized
accreditation schemes (e.g. Joint Commission Interna-
tional and Malaysian Society for Quality in Healthcare)
and state-of-the-art medical equipment in order to devel-
op technology-intensive private health care facilities and
ensure ‘world-class’ care standards considered necessary
to attract medical tourists (12, 1).
With the 2010 launch of the Economic Transformation
Program (ETP), intended to transform Malaysia into an
upper middle-income country with a knowledge-based
economy, interest in harnessing medical tourism’s eco-
nomic potential grew. The ETP earmarked health care as
one of the country’s 12 National Key Economic Areas
(NKEAs) deemed to have the potential to spur growth
(13). Part of the health care NKEA, medical tourism is
intended to generate MYR 9.6 billion1 in revenue and
MYR 4.3 billion in gross national income and to require
5,300 more medical professionals by 2020 (14). For-profit
hospitals are expected to invest MYR 335 million in
hospital infrastructure in order to be prepared for 1.9
million foreign patients annually by 2020 (14). Despite
the specificity of these targets, however, scant empirical
data are publicly available to evaluate whether these
targets are being met and, indeed, even the basis for such
projections.
Medical tourism is believed to be contributing to the
national economy. Government-reported revenue from
medical tourism in Malaysia amounted to MYR 683
million  9% above its 2013 target (15). Although this
added only 0.1% to Malaysia’s MYR 985 billion gross
domestic product (GDP) in 2013 (16), medical tourism’s
year-on-year double-digit growth is being used to attract
foreign investment and joint ventures in the Malaysian
health care industry (e.g. the 2013 Ramsay Sime Darby
Healthcare joint venture (17)). Large Malaysian health
care conglomerates also plan to reap economic gains
from medical tourism despite its current limited contri-
bution. For example, although medical tourism contrib-
uted only 4% (MYR 67 million) to KPJ Healthcare Bhd’s
2013 overall revenue, KPJ expects this to rise to 25%
by 2020 by more intensively promoting its Malaysian
facilities (15, 18).
Although growing numbers of Malaysian health care
facilities are actively promoting medical tourism, some
95% of Malaysian private hospitals’ clientele is reported
to be Malaysian (19). Private and corporatized hospitals’
medical tourism revenue, therefore, is viewed as helping to
not only sustain but also upgrade these facilities to local
private health care users’ benefit, providing Malaysians
with alternatives to crowded public health care provision.
Investment in medical tourism infrastructure is further-
more considered to generate demand for goods and
services in allied sectors (e.g. clinical research and devel-
opment, pharmaceuticals, and medical equipment) (14).
Transport, retail, commercial care, and hospitality sectors
can also benefit from spending by medical tourists and
their companions, generating medical- and non-medical
jobs and spurring the growth not just of large but also
small and medium enterprises (1, 10). Local businesses
in Kuching, Melaka, and Johor Bahru, for example, are
seen to be flourishing with the influx of cross-border
1The current exchange rate is USD 1MYR 3.2.
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Indonesian and Singaporean medical tourists. However,
to date, no empirical evidence is available on the multiplier
effect of medical tourism on other sectors and local
economies. Such data would help to elucidate the effec-
tiveness of government investment in the growth of the
medical tourism industry.
Critics’ perspective
Malaysia’s development as a medical tourism destination
has unfolded within a context of health care corporatiza-
tion and privatization that has profoundly transformed
the country’s health care landscape and horizons (20, 21).
Critics see medical tourism as an expression of health care
commodification, highlighting the Malaysian state’s mul-
tiple roles as funder and provider of public-sector health
care, regulator, and pre-eminent investor in commercial
health care.
Medical tourism is embedded in a broader political
economy in which social services have been devolved to for-
profit enterprise and ‘market-capable’ segments of society
have become sites of intensive entrepreneurial investment
by both the private sector and the state (7). Critics note,
for example, that, although private hospitals account
for approximately 30% of all hospital admissions (22),
government-linked companies at both federal and pro-
vincial levels currently control more than 40% of
commercial hospital beds in Malaysia (23). Among the
country’s most prominent hospitals endorsed for medical
tourism are for-profit hospitals belonging to the Johor
State Governmentowned KPJ chain and the IHH
Healthcare Bhdowned Pantai and Gleneagles chains.
IHH, the world’s second-largest listed health care opera-
tor based on market capitalization, is majority-owned by
the Malaysian government’s sovereign investment arm,
Khazanah (24). Both KPJ and IHH command ever-larger
slices of the Asian health care market both through their
acquisition of regional hospitals (e.g. KPJ’s acquisitions
in Indonesia and Bangladesh) and their promotion of
medical tourism in Malaysia.2
This novel situation is perceived to be rife with
conflicts of interest and divergent priorities (7, 20, 21).
Although health care is not inscribed in the Malaysian
constitution as a right, Malaysian nationals have become
accustomed to de facto entitlement to publicly provided
and highly subsidized health care since decolonization in
1957. Citizens may or may not avail themselves of this
universalist entitlement, yet even those who do not do so
still benefit from its second-order effects. The availability
of publicly provided health care (of a certain quality) acts
as a restraining price bulwark that helps to keep private
health care charges within a more affordable range. With
the state’s increasing stakes in commercial health care
however, will there be a benign neglect of the public
sector as the state encourages those who can afford it to
migrate to the private sector for their healthcare needs?
This could further entrench a two-tier health care system,
with deluxe priority care for the better-off (including
‘medical tourists’) and a rump, underfunded public sector
for the rest (25, 26).
Might Malaysians, however, benefit indirectly from prof-
its accruing to the public purse from medical tourism and
other for-profit healthcare investments? The Malaysian
national oil company Petronas’ total equity is approxi-
mately ten times that of IHH. Comparing the MYR 87.8
million that IHH paid in corporate taxes to the Malaysian
government in FY2011 with the MYR 66.3 billion in taxes
and dividends generated by Petronas in FY2012 suggests
modest returns on IHH’s healthcare investments (27, 28).
As for where revenue derived from medical tourism goes
(e.g. special taxation regimes, economic leakages), little is
known, and discussions about corporate accountability
are absent.
Conclusions
The debate over the gains and adverse effects of ‘medical
tourism’ is far from Malaysia-specific. Rather, it is a con-
cern shared by medical tourism destinations more gen-
erally (as in Israel (29) and Costa Rica (30)). However,
given the great margin of uncertainty over basic data
about medical tourism, conclusions on both sides are
unavoidably speculative. Indeed, it is possible to assume 
as we have shown here  diametrically opposed positions
on the issue with little prospect of resolution.
There is much work to be done in order to better grasp
medical tourism’s actual impacts on destinations. This
first requires us  as policymakers, industry actors,
scholars, citizens, and consumers  to acknowledge not
only medical tourism’s imbrication in a broader range of
transnational care pursuits and provision but also medical
tourism’s articulation in a broader (and increasingly
global) political economy of health care. This would allow
us to start asking more astute questions about the ways in
which different stakeholders conceptualize ‘medical tour-
ism’ and to begin to measure variables that enable analyses
that transcend disembodied claims about growth (31).
This also requires us to acknowledge that medical
facilities and the diverse communities in which they are
inserted receive different volumes and types of foreign
patients that may or may not be ‘medical tourists’, with
their own unique needs, wants, socioeconomic and poli-
tical statuses, and spending patterns. To better respond
to this de facto diversity, the knowledge we produce about
medical tourism must be useful to identify, plan for,
2Currently, however, non-government-linked companies (e.g. Island
Hospital and Penang Adventist Hospital) attract the lion’s share of
medical tourism to Malaysia.
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and develop resources appropriate to the needs, demands,
and interests of not only medical tourists and big business
but also local populaces.
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